Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Metronidazole 1% cream in rosacea
NCT05861310Phase 1Unknown
- Start
- May 2023
- Primary completion
- Jul 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, double-blind trial of metronidazole in rosacea. Primary endpoints: Clinician Erythema Assessment at 56 days and Dermoscopy Examination at 56 days. Status: unknown.
02
Drugs
metronidazole
03
Conditions
rosacea
Beyond the preview
Go deeper on NCT05861310.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05861310.